Do disease-modifying anti-rheumatic drugs affect implant-based breast reconstruction outcomes in patients with autoimmune connective tissue disease?
{{output}}
Background: As breast implants gain popularity, there remains concern over implant safety. Roughly 8% of the U.S population lives with an autoimmune disease, yet there is a paucity of literature comparing outcomes between patient... ...
